February 2026
The global obesity GLP-1 market size was evaluated at USD 8.21 billion in 2025 and is predicted to hit around USD 66.57 billion by 2035, growing at a CAGR of 23.28%.
March 2026
The global anti-obesity drugs market size is estimated at USD 7.14 billion in 2025, and is projected to hit around USD 64.96 billion by 2035, with a CAGR of 24.71%.
March 2026
The global oral obesity therapies market size was evaluated at USD 4.35 billion in 2025 and is predicted to hit around USD 9.34 billion by 2035, growing at a CAGR of 7.94%.
August 2025
The global deoxycholic acid obesity drugs market size is estimated to hit around USD 1,830.89 million by 2034 increasing from USD 486.14 million in 2024, with a CAGR of 14.18%.
July 2025
The global lipase inhibitors obesity drugs market size was estimated at USD 1.25 billion in 2024 and is expected to hit around USD 4.94 billion by 2034, growing at a CAGR of 14.72%.
July 2025
The global digital health for obesity market size reached USD 58.59 billion in 2024 and is projected to hit around USD 433.22 billion by 2034 with a CAGR of 22.15%.
September 2025
The global GLP-1 analogues market size was evaluated at USD 49.90 billion in 2024 and is predicted to hit around USD 879.90 billion by 2034, growing at a CAGR of 33.24%.
July 2025
The global mounjaro market size is estimated to hit around USD 78.51 billion by 2034 increasing from USD 14.18 billion in 2024, with a CAGR of 18.67%.
July 2025
The global wegovy market size is estimated to hit around USD 24.53 billion by 2034 increasing from USD 2.44 billion in 2024, with a CAGR of 25.96%.
June 2025
The bariatric surgery devices market size was valued at USD 2.69 billion in 2024 and is expected to reach around USD 4.56 billion by 2034, with a CAGR of 5.43%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com